Dasatinib
Dasatinib is an orally bioavailable, ATP-competitive tyrosine kinase inhibitor targeting Src and Bcr-Abl with high potency (Ki=16/30 pM) . It is widely used in leukemia and lymphoma research, demonstrating antitumor efficacy in both in vitro cellular assays and in vivo animal models of cancer.
Product Specifications
CAS Number
302962-49-8
Product Name Alternative
BMS-354825
Field of Research
Cell Biology, Immunology & Inflammation
Purity
>98%
Bioactivity
Src and Bcr/Abl inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 200 mg/ml) .
Smiles
N (C1=CC (N2CCN (CCO) CC2) =NC (C) =N1) C=3SC (C (NC4=C (C) C=CC=C4Cl) =O) =CN3
Molecular Formula
C22H26ClN7O2S
Molecular Weight
488.0
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N- (2-chloro-6-methylphenyl) -2- (6- (4- (2-hydroxyethyl) -piperazin-1-yl) -2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
